Health Care & Life Sciences » Pharmaceuticals | Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd.
Stock Exchange Bombay Stock Exchange Prices
EPS
INR8.62
Market Cap
INR273.44 M
Shares Outstanding
3.09 M
Public Float
-

Profile

Address
701/702, Business Square
Mumbai Maharashtra 400058
India
Employees -
Website http://www.samratpharmachem.com
Updated 09/14/2018
Samrat Pharmachem Ltd. engages in the manufacture of iodine and bromine salts. Its products include 3-5-Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, and barium, copper, and zinc iodide. The company was founded by Lalit Damodar Mehta on June 16, 1992 and is headquartered in Mumbai, India.

Financials

View All

Lalit Damodar Mehta
Chairman & Managing Director
Rajesh Lalit Mehta
CFO & Non-Independent Executive Director